Skip to main content
VCbacked
Log inGet Started

Avidicure

Oegstgeest, The Netherlands

Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.

$50.0M raised
Apr 2025
Seed

Top Investors

EQT Life SciencesKurma PartnersV-Bio VenturesBioGeneration VenturesBOM

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avidicure

How much funding has Avidicure raised?
Avidicure has raised $50.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Who are Avidicure's investors?
Avidicure's investors include EQT Life Sciences, Kurma Partners, V-Bio Ventures, BioGeneration Ventures, BOM.
Where is Avidicure headquartered?
Avidicure is headquartered in Oegstgeest, The Netherlands.
What does Avidicure do?
Avidicure is pioneering an entirely new dual agonistic, multifunctional and avidity engineered antibody modality.
What stage is Avidicure at?
Avidicure is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Avidicure — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/avidicure. Accessed June 30, 2026.
APA
VCBacked. (2025). Avidicure — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/avidicure
Wikipedia (cite web)
{{cite web |title=Avidicure — Funding & Investors |url=https://www.vcbacked.co/company/avidicure |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .